Promising new drug shows hope for tough bladder cancer cases
NCT ID NCT04995419
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 31 times
Summary
This study tested a drug called enfortumab vedotin in 40 Chinese patients with advanced bladder cancer that had already been treated with chemotherapy and immunotherapy. The goal was to see if the drug could shrink tumors and control the disease. The study measured how well the drug worked and how safe it was, offering a potential new option for patients with limited choices.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC UROTHELIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site CN86001
Beijing, China
-
Site CN86002
Guangzhou, China
-
Site CN86003
Wuhan, China
-
Site CN86004
Shanghai, China
-
Site CN86006
Hangzhou, China
-
Site CN86007
Nanjing, China
-
Site CN86009
Changsha, China
Conditions
Explore the condition pages connected to this study.